Physician
Texas Health Care, P.L.L.C.
Texas Health Care, P.L.L.C. was paid $9.23M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoTEXAS HEALTH CARE, P.L.L.C.
FORT WORTH, TX 76107
FORT WORTH, TX 76107
33aNPI1821026352assigned 06/30/2006
33bProvider typeOphthalmology Physician
28Total paid$9.23M
24GClaims414,122
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Texas
Rank by total paid#1 of 231
Median peer was paid$16K
This provider vs. median591×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,614 | $27K | |
| 2019 | 7,812 | $21K | |
| 2020 | 22,728 | $438K | |
| 2021 | 96,217 | $2.10M | |
| 2022 | 105,983 | $2.54M | |
| 2023 | 92,779 | $2.27M | |
| 2024incomplete | 79,989 | $1.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 48,655 | 34,049 | $1.97M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 59,643 | 44,920 | $1.83M |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 6.7% | 1,115 | 1,079 | $620K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 6.3% | 7,241 | 6,677 | $583K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 4.6% | 4,206 | 4,052 | $427K |
| 59430 | 3.2% | 3,422 | 3,188 | $298K | |
| 81513 | 3.1% | 2,848 | 2,686 | $286K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.7% | 9,255 | 8,719 | $246K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.7% | 9,247 | 8,713 | $246K |
| 81002 | 2.4% | 79,977 | 54,096 | $219K | |
| 99000 | 2.3% | 30,077 | 25,889 | $212K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.9% | 6,907 | 6,420 | $175K |
135 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.9% | 2,203 | $175K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.3% | 1,663 | $125K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.3% | 6,021 | $116K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 1,423 | $105K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.1% | 7,985 | $100K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.0% | 1,163 | $94K |
| 76801 | <1% | 1,022 | $89K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,674 | $85K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 3,414 | $83K |
| 87481 | <1% | 3,085 | $77K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,946 | $74K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 975 | $63K |
| 59514 | <1% | 101 | $61K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 444 | $47K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 730 | $44K |
| 86703 | <1% | 3,903 | $40K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 998 | $40K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 948 | $38K |
| 88141 | <1% | 2,389 | $38K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,646 | $37K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 424 | $37K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 849 | $36K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 789 | $33K |
| 86780 | <1% | 3,172 | $32K | |
| 81025 | <1% | 4,500 | $29K | |
| 87150 | <1% | 1,062 | $28K | |
| 92567 | <1% | 2,302 | $26K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,864 | $24K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,089 | $23K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 575 | $21K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 631 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,344 | $17K |
| 86762 | <1% | 1,476 | $16K | |
| 82950 | <1% | 4,105 | $15K | |
| 84702 | <1% | 1,275 | $14K | |
| 92557 | <1% | 509 | $13K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 186 | $12K |
| 76818 | <1% | 146 | $12K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,477 | $12K |
| 87340 | <1% | 1,486 | $11K | |
| 76830 | Ultrasound, transvaginal | <1% | 115 | $11K |
| 87653 | <1% | 332 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,567 | $9K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 113 | $7K |
| 84481 | <1% | 610 | $7K | |
| 87510 | <1% | 451 | $7K | |
| 87480 | <1% | 446 | $7K | |
| 87660 | <1% | 447 | $7K | |
| 82947 | <1% | 1,707 | $5K | |
| 88142 | <1% | 345 | $5K | |
| 99307 | <1% | 753 | $5K | |
| 99381 | <1% | 68 | $5K | |
| 88174 | <1% | 248 | $4K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 255 | $4K |
| 84439 | <1% | 726 | $4K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 146 | $4K |
| 62370 | <1% | 543 | $4K | |
| 87807 | <1% | 366 | $4K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 391 | $4K |
| 92511 | <1% | 55 | $3K | |
| 86592 | <1% | 992 | $3K | |
| 87625 | <1% | 126 | $3K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 57 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 27 | $3K |
| 92504 | <1% | 211 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 291 | $2K |
| 90461 | <1% | 664 | $2K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,941 | $2K |
| 85027 | <1% | 336 | $2K | |
| 86803 | <1% | 133 | $1K | |
| 90688 | <1% | 102 | $1K | |
| 90715 | <1% | 59 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 705 | $1K |
| 80061 | Lipid panel | <1% | 556 | $1K |
| 84436 | <1% | 243 | $1K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 740 | $1K |
| 82951 | <1% | 95 | $844.19 | |
| 99460 | <1% | 12 | $811.64 | |
| 96160 | <1% | 373 | $757.93 | |
| 87428 | <1% | 15 | $734.90 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 29,350 | $702.27 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 13 | $671.67 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 21 | $560.12 |
| 80050 | General health panel | <1% | 80 | $508.39 |
| 90686 | <1% | 933 | $487.06 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $449.78 |
| 81003 | <1% | 297 | $410.46 | |
| 92134 | <1% | 37 | $332.39 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 13 | $276.60 |
| 82952 | <1% | 82 | $216.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12 | $135.40 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 414 | $131.69 |
| 99223 | Prolong inpt eval add15 m | <1% | 60 | $117.74 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 16 | $98.20 |
| 84156 | <1% | 28 | $85.11 | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 107 | $54.56 |
| 82565 | <1% | 14 | $50.18 | |
| 81015 | <1% | 58 | $43.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 287 | $39.96 |
| 85018 | <1% | 15 | $29.00 | |
| 85014 | <1% | 15 | $29.00 | |
| 3074F | 0% | 414 | $0.00 | |
| 90677 | 0% | 401 | $0.00 | |
| 1036F | 0% | 205 | $0.00 | |
| 90680 | 0% | 679 | $0.00 | |
| 3008F | 0% | 807 | $0.00 | |
| 90656 | 0% | 239 | $0.00 | |
| 90716 | 0% | 393 | $0.00 | |
| 90744 | 0% | 483 | $0.00 | |
| 90698 | 0% | 738 | $0.00 | |
| 90619 | 0% | 51 | $0.00 | |
| 90651 | 0% | 134 | $0.00 | |
| 96161 | 0% | 17 | $0.00 | |
| 99459 | 0% | 115 | $0.00 | |
| 1170F | 0% | 13 | $0.00 | |
| 90696 | 0% | 32 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 32 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 23 | $0.00 |
| 90670 | 0% | 606 | $0.00 | |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 3,439 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 3,731 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 496 | $0.00 |
| 1160F | 0% | 780 | $0.00 | |
| 3078F | 0% | 396 | $0.00 | |
| 90633 | 0% | 443 | $0.00 | |
| 80305 | 0% | 179 | $0.00 | |
| 90707 | 0% | 376 | $0.00 | |
| 1159F | 0% | 779 | $0.00 | |
| 90700 | 0% | 89 | $0.00 | |
| 90648 | 0% | 91 | $0.00 | |
| 99072 | 0% | 74 | $0.00 | |
| 3023F | 0% | 12 | $0.00 | |
| 90710 | 0% | 15 | $0.00 | |
| 1090F | 0% | 13 | $0.00 | |
| 3288F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWLEY, JOHN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Texas Health Care, P.L.L.C. | Willow Park, TX | $1.46M |
| Texas Health Care, P.L.L.C. | Fort Worth, TX | $1.13M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.